Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

Designation based on preliminary clinical evidence indicating the potential for ETX101 to address unmet medical needs associated with SCN1A+ Dravet syndrome Completion of enrollment in POLARIS ...

Percent change measures stock value changes over time, helping compare investments. Tracking percent change reveals investment volatility and trends, assisting risk assessment. Utilize percent change ...

History shows that when just 3.5 percent of a population—about 12 million Americans—engage in peaceful protest, their demands become nearly impossible to ignore. This is particularly relevant today, ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

AAV9-based Angelman Syndrome candidate, ETX201, demonstrates safety and target engagement in non-human primates (NHPs), with unsilencing of UBE3A across disease-relevant brain regions Multiple ...

The MIPI Alliance has recently released the MIPI C-PHY v3.0 specification, defining the physical layer for connecting cameras and displays. The main change in MIPI C-PHY Version 3.0 is the addition of ...

NEW YORK – Encoded Therapeutics on Thursday said it has laid off 29 percent of its employees in a move to fund operations through the third quarter of 2026. The layoffs primarily affect technology and ...